Prelude Capital Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,000
Closed -$722K 1954
2019
Q4
$722K Hold
10,000
0.03% 475
2019
Q3
$1.4M Hold
10,000
0.06% 252
2019
Q2
$1.83M Buy
+10,000
New +$1.71M 0.09% 214

Other funds holding SAGE